Xingchen Peng
Clinical trials sponsored by Xingchen Peng, explained in plain language.
-
New hope for Hard-to-Treat cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called IL-22BP/LNP in people with advanced solid tumors (like sarcoma, head and neck cancer, or melanoma) that have not responded to standard treatments. The main goals are to check the drug's safety and see if it can shrink tumors. Only 6 …
Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control
Last updated May 26, 2026 06:24 UTC
-
New app aims to fight malnutrition in cancer patients
Symptom relief Recruiting nowThis study tests a web-based app to help cancer patients manage their nutrition. Researchers will enroll 84 people with cancer in communities near Chengdu, China. Participants will use the app to track diet and activity, and those at nutritional risk will get face-to-face counsel…
Phase: NA • Sponsor: Xingchen Peng • Aim: Symptom relief
Last updated May 26, 2026 06:30 UTC